Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00432367Phase 3Completed
Phase 3, randomised, open-label trial of artesunate + amodiaquine in malaria (3 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Prevalence of severe maternal anaemia (Hb < 8g/dl). Started Feb 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00432367.